Skip to main content

Advertisement

Log in

Health-related quality of life of head and neck cancer patients with successful oncological treatment

  • Head and Neck
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

Oncological treatment of head and neck carcinoma is associated with high morbidity. Measuring of health-related quality of life (HRQoL) is crucial in this patient group but there is no consensus on which measure would be preferable to be used. In this study, HRQoL was measured with the generic 15D, which has not been used before for assessing this patient population. It is a prospective cohort study among 64 patients with laryngeal, pharyngeal or nasal cavity carcinoma treated with definitive (chemo) radiotherapy between November 2007−July 2012. HRQoL was assessed with the 15D before and at 3, 6 and 12 months after the treatment onset. HRQoL results of the patients were compared with those of the age-standardized general population. Overall HRQoL declined significantly during the first 3 months after the treatment onset but then gradually improved towards the end of the follow-up. At baseline or at 12 months, no significant differences were detected in overall HRQoL between the patients and the general population. Dimensions reflecting mental well-being showed gradual improvement, exceeding the baseline scores at the end of the follow-up. Nevertheless, on these dimensions, the patient group presented with consistently lower scores compared with the general population. The mean HRQoL was lower among patients with pharyngeal carcinoma compared with the laryngeal carcinoma patients. The 15D instrument is feasible for evaluation of HRQoL in oncologically treated head and neck cancer patients. It seems to detect differences among different patient subgroups. Multidisciplinary supportive management of this patient population is recommended to ensure improved mental well-being.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. http://www.cancer.fi/syoparekisteri/en/statistics/cancer-statistics/koko-maa/. Accessed January 2014

  2. Pignon JP, Bourhis J, Domenge C, Designé L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949–955

    Article  CAS  PubMed  Google Scholar 

  3. Pignon JP, Le Maître A, Bourhis J (2007) Meta-analyses of chemotherapy in head and neck cancer (MACH-NC): an update. Int J Radiat Oncol Biol Phys 69:S112–S114

    Article  PubMed  Google Scholar 

  4. Pignon JP, Le Maître A, Maillard E, Bourhis J, MACH-NC Collaborative Group (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14

    Article  PubMed  Google Scholar 

  5. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098

    Article  CAS  PubMed  Google Scholar 

  6. Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ (2008) Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol 26:3770–3776

    Article  PubMed  Google Scholar 

  7. Pow EH, Kwong DL, McMillan AS, Sham JS, Leung LH, Leung WK (2006) Xerostomia and quality of life after intensity modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal cancer. Int J Radiat Oncol Biol Phys 66:981–991

    Article  PubMed  Google Scholar 

  8. Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A’Hern RP, Sydenham MA, Emson M, Hall E; PARSPORT trial management group (2011) Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 12:127–136

    Article  PubMed Central  PubMed  Google Scholar 

  9. Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, Lai M, Ho R, Cheung KY, Yu BK, Chiu SK, Choi PH, Teo PM, Kwan WT, Chan AT (2007) Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 25:4873–4879

    Article  PubMed  Google Scholar 

  10. Rogers SN, Ahad SA, Murphy AP (2007) A structured review and theme analysis of papers published on ‘quality of life’ in head and neck cancer: 2000-2005. Oral Oncol 43:843–868

    Article  CAS  PubMed  Google Scholar 

  11. Murphy BA (2009) Advances in quality of life and symptom management for head and neck cancer patients. Curr Opin Oncol 21:242–247

    Article  PubMed  Google Scholar 

  12. Ringash J, Bezjak A (2001) A structured review of quality of life instruments for head and neck cancer patients. Head Neck 23:201–213

    Article  CAS  PubMed  Google Scholar 

  13. Sherman AC, Simonton S (2010) Advances in quality of life research among head and neck cancer patients. Curr Oncol Rep 12:208–215

    Article  PubMed  Google Scholar 

  14. Mauer ME, Bottomley A, Coens C, Gotay C (2008) Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation. Expert Rev Pharmacoecon Outcomes Res 8:179–196

    Article  PubMed  Google Scholar 

  15. Ilonen IK, Räsänen JV, Sihvo EI, Knuuttila A, Sovijärvi AR, Sintonen H, Salo JA (2007) Pneumonectomy: post-operative quality of life and lung function. Lung Cancer 58:397–402

    Article  PubMed  Google Scholar 

  16. Ilonen IK, Räsänen JV, Knuuttila A, Sihvo EI, Sintonen H, Sovijärvi AR, Salo JA (2010) Quality of life following lobectomy or bilobectomy for non-small cell lung cancer, a two-year prospective follow-up study. Lung Cancer 70:347–351

    Article  PubMed  Google Scholar 

  17. Färkkilä N, Torvinen S, Roine RP, Sintonen H, Hänninen J, Taari K, Saarto T (2013) Health-related quality of life among breast, prostate, and colorectal cancer patients with end-stage disease. Qual Life Res 23(4):1387–1394 (Epub ahead of print)

    Article  PubMed  Google Scholar 

  18. Färkkilä N, Sintonen H, Saarto T, Järvinen H, Hänninen J, Taari K, Roine R (2013) Health-related quality of life in colorectal cancer. Colorectal Dis 15:e215–e222

    Article  PubMed  Google Scholar 

  19. Torvinen S, Färkkilä N, Sintonen H, Saarto T, Roine RP, Taari K (2013) Health-related quality of life in prostate cancer. Acta Oncol 52:1094–1101

    Article  PubMed  Google Scholar 

  20. Ilmarinen T, Nissilä H, Rihkanen H, Roine RP, Pietarinen-Runtti P, Pitkäranta A, Aaltonen LM (2011) Clinical features, health-related quality of life, and adult voice in juvenile-onset recurrent respiratory papillomatosis. Laryngoscope 121:846–851

    Article  PubMed  Google Scholar 

  21. Hytönen M, Lilja M, Mäkitie AA, Sintonen H, Roine RP (2012) Does septoplasty enhance the quality of life in patients? Eur Arch Otorhinolaryngol 269:2497–2503

    Article  PubMed  Google Scholar 

  22. Wikstén J, Blomgren K, Roine RP, Sintonen H, Pitkäranta A (2013) Effect of tonsillectomy on health-related quality of life and costs. Acta Otolaryngol 133:499–503

    Article  PubMed  Google Scholar 

  23. Sintonen H (2001) The 15D instrument of health-related quality of life: properties and applications. Ann Med 33:328–336

    Article  CAS  PubMed  Google Scholar 

  24. Alanne S (2011) Subjectively significant change in the measurement of health-related quality of life. Department of health policy and management, faculty of social sciences and business studies, University of Eastern Finland, pp 1-64

  25. Aromaa A, Koskinen S (eds) (2004) Health and functional capacity in Finland. Baseline results of the health 2000 health examination survey. Hakapaino Oy, Helsinki

    Google Scholar 

  26. Saarilahti K, Kouri M, Collan J, Hämäläinen T, Atula T, Joensuu H, Tenhunen M (2005) Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol 74:251–258

    Article  PubMed  Google Scholar 

  27. Saarilahti K, Kouri M, Collan J, Kangasmäki A, Atula T, Joensuu H, Tenhunen M (2006) Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer. Radiother Oncol 78:270–275

    Article  PubMed  Google Scholar 

  28. Tenhunen M, Collan J, Kouri M, Kangasmäki A, Heikkonen J, Kairemo K, Mäkitie A, Joensuu H, Saarilahti K (2008) Scintigraphy in prediction of the salivary gland function after gland-sparing intensity-modulated radiation therapy for head and neck cancer. Radiother Oncol 87:260–267

    Article  PubMed  Google Scholar 

  29. Loimu V, Collan J, Vaalavirta L, Bäck L, Kapanen M, Mäkitie A, Tenhunen M, Saarilahti K (2011) Patterns of relapse following definitive treatment of head and neck cancer squamous cell cancer by intensity modulated radiotherapy and weekly cisplatin. Radiother Oncol 98:34–37

    Article  CAS  PubMed  Google Scholar 

  30. Räsänen P, Krootila K, Sintonen H, Leivo T, Koivisto A-M, Ryynänen O-P, Blom M, Roine RP (2006) Cost-utility of routine cataract surgery. Health Qual Life Outcomes 4:74

    Article  PubMed Central  PubMed  Google Scholar 

  31. Räsänen P, Paavolainen P, Sintonen H, Koivisto A-M, Blom M, Ryynänen O-P, Roine RP (2007) Effectiveness of hip or knee replacement surgery in terms of quality-adjusted life years and costs. Acta Orthop 78:108–115

    Article  PubMed  Google Scholar 

  32. Tykkä E, Räsänen P, Tukiainen E, Asko-Seljavaara S, Heikkilä A, Sintonen H, Roine RP (2010) Cost-utility of breast reduction surgery. A prospective study. J Plast Reconstr Aesthet Surg 63:89–92

    Article  Google Scholar 

  33. Taipale K, Leminen A, Räsänen P, Heikkilä A, Tapper A-M, Sintonen H, Roine RP (2009) Costs and health-related quality of life effects of hysterectomy in patients with benign uterine disorders. Acta Obstet Gynecol Scand 88:1402–1410

    Article  PubMed  Google Scholar 

  34. Pohjolainen V, Räsänen P, Roine R, Sintonen H, Wahlbeck K, Karlsson H (2010) Cost-utility of treatment of bulimia nervosa. Int J Eat Disord 43:596–602

    Article  PubMed  Google Scholar 

  35. Suominen K, Karlsson H, Rissanen A, Valtonen HM, Räsänen P, Sintonen H, Roine RP (2011) Perceived burden of illness in patients entering for treatment in a university hospital—is the threshold to secondary care higher for patients with depression than for those with somatic disorders? Eur Psychiatry 26:441–445

    Article  CAS  PubMed  Google Scholar 

  36. Hammerlid E, Taft C (2001) Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms. Br J Cancer 84:149–156

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  37. Bjordal K, Alhner-Elmqvist M, Hammerlid E, Boysen M, Evensen JF, Björklund A, Jannert M, Westin T, Kaasa S (2001) A prospective study of quality of life in head and neck cancer patientsPart II: Longitudinal data. Laryngoscope 111:1440–1452

    Article  CAS  PubMed  Google Scholar 

  38. Chen A, Daly M, Farwell G, Vazquez E, Courquin J, Lau D, Purdy J (2014) Quality of life among long-term survivors of head and neck cancer treated by intensity-modulated radiotherapy. JAMA Otolaryngol Head Neck Surg 140:129–133

    Article  PubMed  Google Scholar 

  39. Fang FM, Tsai WL, Chien CY, Chen HC, Hsu HC, Huang TL, Lee TF, Huang HY, Lee CH (2010) Pretreatment quality of life as a predictor of distant metastasis and survival for patients with nasopharyngeal carcinoma. J Clin Oncol 28:4384–4389

    Article  PubMed  Google Scholar 

  40. Meyer F, Fortin A, Gélinas M, Nabid A, Brochet F, Têtu B, Bairati I (2009) Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy. J Clin Oncol 27:2970–2976

    Article  PubMed  Google Scholar 

  41. de Graeff A, de Leeuw JRJ, Ros WJG, Hordijk GJ, Blijham GH, Winnubst JAM (2001) Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer 37:332–339

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The Helsinki University Central Hospital Research Funds.

Conflict of interest

None to declare.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to V. Loimu.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Loimu, V., Mäkitie, A.A., Bäck, L.J. et al. Health-related quality of life of head and neck cancer patients with successful oncological treatment. Eur Arch Otorhinolaryngol 272, 2415–2423 (2015). https://doi.org/10.1007/s00405-014-3169-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-014-3169-1

Keywords

Navigation